While regulation of iron metabolism-related proteins or the use of iron chelators can reduce intracellular labile Fe 2+ levels and inhibit ferroptosis, current chelators lack tissue and cellular specificity and may interfere with neurophysiological functions, thereby limiting their clinical applicability
The supplement industry can help by declaring research chemicals are not dietary supplements to make it clear to consumers that supplements and research chemicals are not the same thing
Sustained glycemic control through one year: Minimal change in HbA1c levels was observed after the Revita procedure (0.08% 0.08%
They also define who can enroll, what labs are checked, how side effects are handled, and when treatment should pause or stop
Gamradt S, Hasselmann H, Taenzer A, Brasanac J, Stiglbauer V, Sattler A, et al